The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress

Dunnigan‐type familial partial lipodystrophy (FPLD) is a laminopathy characterized by an aberrant fat distribution and a metabolic syndrome for which oxidative stress has recently been suggested as one of the disease‐causing mechanisms. In a family affected with FPLD, we identified a heterozygous missense mutation c.1315C>T in the LMNA gene leading to the p.R439C substitution. Cultured patient fibroblasts do not show any prelamin A accumulation and reveal honeycomb‐like lamin A/C formations in a significant percentage of nuclei. The mutation affects a region in the C‐terminal globular domain of lamins A and C, different from the FPLD‐related hot spot. Here, the introduction of an extra cysteine allows for the formation of disulphide‐mediated lamin A/C oligomers. This oligomerization affects the interaction properties of the C‐terminal domain with DNA as shown by gel retardation assays and causes a DNA‐interaction pattern that is distinct from the classical R482W FPLD mutant. Particularly, whereas the R482W mutation decreases the binding efficiency of the C‐terminal domain to DNA, the R439C mutation increases it. Electron spin resonance spectroscopy studies show significantly higher levels of reactive oxygen species (ROS) upon induction of oxidative stress in R439C patient fibroblasts compared to healthy controls. This increased sensitivity to oxidative stress seems independent of the oligomerization and enhanced DNA binding typical for R439C, as both the R439C and R482W mutants show a similar and significant increase in ROS upon induction of oxidative stress by H2O2.

[1]  B. Donadille,et al.  New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  C. Bodemer,et al.  Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence , 2007, Cell Death and Differentiation.

[3]  J. Broers,et al.  The nuclear envelope, a key structure in cellular integrity and gene expression. , 2007, Current medicinal chemistry.

[4]  A. Legrand,et al.  Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation , 2007, Free radical research.

[5]  H. Smeets,et al.  Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. , 2006, Human molecular genetics.

[6]  J. Broers,et al.  Nuclear lamins: laminopathies and their role in premature ageing. , 2006, Physiological reviews.

[7]  L. Leichert,et al.  Global methods to monitor the thiol-disulfide state of proteins in vivo. , 2006, Antioxidants & redox signaling.

[8]  David J. Chen,et al.  Genomic instability in laminopathy-based premature aging , 2005, Nature Medicine.

[9]  G. Novelli,et al.  Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. , 2005, Human molecular genetics.

[10]  E. Kuipers,et al.  The presence of the cag pathogenicity island is associated with increased superoxide anion radical scavenging activity by Helicobacter pylori. , 2005, FEMS immunology and medical microbiology.

[11]  E. Lane,et al.  Cell cycle changes in A-type lamin associations detected in human dermal fibroblasts using monoclonal antibodies , 1997, Chromosome Research.

[12]  G. Boriani,et al.  Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes , 2003, Journal of medical genetics.

[13]  A. K. Agarwal,et al.  Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. , 2003, Diabetes care.

[14]  S. Zinn-Justin,et al.  The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. , 2003, Biochemistry.

[15]  J. Broers,et al.  Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. , 2002, European journal of cell biology.

[16]  C. Hutchison.  Lamins: building blocks or regulators of gene expression? , 2002, Nature Reviews Molecular Cell Biology.

[17]  S. Zinn-Justin,et al.  The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. , 2002, Structure.

[18]  S. Shoelson,et al.  Structure of the Globular Tail of Nuclear Lamin* , 2002, The Journal of Biological Chemistry.

[19]  R. Goldman,et al.  Nuclear lamins: building blocks of nuclear architecture. , 2002, Genes & development.

[20]  C. Vigouroux,et al.  Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. , 2001, Journal of cell science.

[21]  C. Hutchison,et al.  Expression of individual lamins in basal cell carcinomas of the skin , 2001, British Journal of Cancer.

[22]  A. Bowcock,et al.  Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  R. Goldman,et al.  Nuclear Lamins a and B1: Different Pathways of Assembly during Nuclear Envelope Formation in Living Cells , 2000 .

[24]  R. Trembath,et al.  Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. , 2000, Diabetes.

[25]  J. Courvalin,et al.  Inner nuclear membrane protein LBR preferentially interacts with DNA secondary structures and nucleosomal linker. , 2000, Biochemistry.

[26]  R. Hegele,et al.  Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. , 2000, Genome research.

[27]  E M Manders,et al.  Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. , 1999, Journal of cell science.

[28]  A. Ciccodicola,et al.  SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function. , 1995, Human molecular genetics.

[29]  J. Broers,et al.  Abnormal A-type lamin organization in a human lung carcinoma cell line. , 1995, European journal of cell biology.

[30]  A. Sasseville,et al.  Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. , 1995, Journal of cell science.

[31]  E. Maestrini,et al.  Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy , 1994, Nature Genetics.

[32]  M. Sinensky,et al.  An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing. , 1994, Cancer research.

[33]  N. Chaudhary,et al.  Stepwise reassembly of the nuclear envelope at the end of mitosis , 1993, The Journal of cell biology.

[34]  J. Bridger,et al.  Internal lamin structures within G1 nuclei of human dermal fibroblasts. , 1993, Journal of cell science.

[35]  G. Dessev,et al.  Lamin dimers. Presence in the nuclear lamina of surf clam oocytes and release during nuclear envelope breakdown. , 1990, The Journal of biological chemistry.

[36]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[37]  J. Tooze,et al.  A monoclonal antibody which recognises each of the nuclear lamin polypeptides in mammalian cells. , 1983, The EMBO journal.

[38]  D. Cochran,et al.  Oligomeric structure of the major nuclear envelope protein lamin B. , 1982, The Journal of biological chemistry.

[39]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.